HIV Antibody Clinical Trials

• Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00014560 - Active, not recruiting
  Lymphocytic Lymphoma; Non-Hodgkin's Lymphoma
  
• Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00009776 - Active, not recruiting
  Burkitt's Lymphoma; Lymphocytic Lymphoma
  
• Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002560 - Active, not recruiting
  recurrent neuroblastoma
  
• Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006347 - Active, not recruiting
  Recurrent Small Cell Lung Cancer
  
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors
  ClinicalTrials.gov Identifier: NCT00003478 - Active, not recruiting
  adult brain tumor
  
• Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00008021 - Active, not recruiting
  Burkitt's Lymphoma; Lymphoblastic Lymphoma; Myeloid Leukemia
  
• beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00037011 - Active, not recruiting
  disseminated neuroblastoma; recurrent neuroblastoma
  
• Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00009750 - Active, not recruiting
  stage IV prostate cancer; recurrent prostate cancer
  
• Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00007826 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
  ClinicalTrials.gov Identifier: NCT00089245 - Recruiting
  Cancer
  
• Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00003082 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Radiolabeled Monoclonal Antibody in Treating Patients With Previously Treated Large Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00028613 - Active, not recruiting
  recurrent adult diffuse large cell lymphoma
  
• Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00005813 - Active, not recruiting
  adult glioblastoma multiforme
  
• Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors
  ClinicalTrials.gov Identifier: NCT00003484 - Active, not recruiting
  Central Nervous System Tumor; Brain Tumor
  
• Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00027729 - Active, not recruiting
  recurrent colon cancer; recurrent rectal cancer
  
• Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00009763 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
  ClinicalTrials.gov Identifier: NCT00058396 - Active, not recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia
  
• Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00004110 - Active, not recruiting
  regional neuroblastoma; disseminated neuroblastoma; recurrent neuroblastoma; localized unresectable neuroblastoma
  
• Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00024232 - Active, not recruiting
  stage IV prostate cancer; recurrent prostate cancer
  
• Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00040950 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00003023 - Active, not recruiting
  childhood soft tissue sarcoma; Muscle Cancer; Neuroblastoma; Osteosarcoma
  
• Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006352 - Active, not recruiting
  limited stage small cell lung cancer
  
• Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003337 - Active, not recruiting
  Lymphoma
  
• Monoclonal Antibody Therapy Plus Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00005940 - Active, not recruiting
  adult acute myeloid leukemia in remission
  
• Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma
  ClinicalTrials.gov Identifier: NCT00004017 - Active, not recruiting
  recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma
  
• CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery
  ClinicalTrials.gov Identifier: NCT00090896 - Active, not recruiting
  Recurrent Melanoma; stage III melanoma; Stage IV Melanoma
  
• Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00039273 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
  
• Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00004177 - Active, not recruiting
  recurrent ovarian epithelial cancer
  
• Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00047151 - Active, not recruiting
  recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer
  
• Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00003963 - Active, not recruiting
  Waldenstrom's Macroglobulinemia; adult non-Hodgkin's lymphoma
  
• Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003920 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Monoclonal Antibody Therapy and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer
  ClinicalTrials.gov Identifier: NCT00028483 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer
  ClinicalTrials.gov Identifier: NCT00004879 - Active, not recruiting
  Colorectal Cancer; Esophageal Cancer; kidney tumor; Lung Cancer; Pancreatic Cancer; Prostate Cancer
  
• A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers
  ClinicalTrials.gov Identifier: NCT00000774 - Active, not recruiting
  HIV Infections; HIV Seronegativity
  
• A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers
  ClinicalTrials.gov Identifier: NCT00000879 - Active, not recruiting
  HIV Infections; HIV Seronegativity
  
• Chemotherapy With or Without Monoclonal Antibody in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00012285 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• A Study to Test the Safety of Three Experimental HIV Vaccines
  ClinicalTrials.gov Identifier: NCT00000946 - Active, not recruiting
  HIV Infections; HIV Seronegativity
  
• Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00045617 - Active, not recruiting
  limited stage small cell lung cancer
  
• Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy
  ClinicalTrials.gov Identifier: NCT00066547 - Active, not recruiting
  recurrent breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
  
• Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00001110 - Active, not recruiting
  HIV Infections
  
• Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00012233 - Active, not recruiting
  Stage IV rectal cancer; stage IV colon cancer
  
• HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults
  ClinicalTrials.gov Identifier: NCT00013572 - Active, not recruiting
  HIV Infections; HIV Seronegativity
  
• Monoclonal Antibody Therapy Compared With No Further Therapy After Surgery in Treating Patients With Stage II Colon Cancer
  ClinicalTrials.gov Identifier: NCT00002968 - Active, not recruiting
  stage II colon cancer; adenocarcinoma of the colon
  
• Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00084656 - Recruiting
  intraocular melanoma; Melanoma
  
• Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00052403 - Recruiting
  unspecified adult solid tumor, protocol specific
  
• Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00054574 - Active, not recruiting
  recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• A Study of the Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine
  ClinicalTrials.gov Identifier: NCT00001136 - Active, not recruiting
  HIV Infections; HIV Seronegativity
  
• Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy
  ClinicalTrials.gov Identifier: NCT00004115 - Active, not recruiting
  stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
  
• Effects of Therapeutic HIV Vaccination on Control of HIV after Discontinuation of Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00050063 - Active, not recruiting
  HIV Infections
  
• Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00016159 - Active, not recruiting
  adult acute myeloid leukemia in remission; childhood acute myeloid leukemia in remission; adult acute promyelocytic leukemia (M3); ...
  
• Pre-HIV Test Counseling Intervention to Reduce HIV Infection Risk Behavior in Men Who Are Not HIV Infected
  ClinicalTrials.gov Identifier: NCT00218699 - Active, not recruiting
  HIV Infections
  
• Monoclonal Antibody Therapy in Treating Patients With Brain Metastases
  ClinicalTrials.gov Identifier: NCT00002751 - Active, not recruiting
  leptomeningeal metastases
  
• Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases
  ClinicalTrials.gov Identifier: NCT00060138 - Active, not recruiting
  Hypercalcemia; stage IV breast cancer; recurrent breast cancer; bone metastases; Pain
  
• Safety and Effectiveness of Administering an HIV Vaccine in the Groin versus the Arm
  ClinicalTrials.gov Identifier: NCT00076817 - Active, not recruiting
  HIV Infections; HIV Seronegativity
  
• Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00032019 - Active, not recruiting
  adult diffuse large cell lymphoma; adult immunoblastic large cell lymphoma
  
• Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP
  ClinicalTrials.gov Identifier: NCT00076037 - Active, not recruiting
  HIV Infections; HIV Seronegativity
  
• Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon alfa in Treating Patients With Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00002734 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients
  ClinicalTrials.gov Identifier: NCT00080106 - Active, not recruiting
  HIV Infections
  
• Effectiveness of Treating HIV-Positive Patients with an HIV Vaccine (Remune)
  ClinicalTrials.gov Identifier: NCT00005002 - Active, not recruiting
  HIV Infections
  
• Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients with Acute or Recent HIV Infection
  ClinicalTrials.gov Identifier: NCT00183261 - Active, not recruiting
  HIV Infections
  
• Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00003868 - Active, not recruiting
  adult acute myeloid leukemia; childhood acute myeloid leukemia; secondary acute myeloid leukemia
  
• Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00027261 - Active, not recruiting
  HIV Infections; HIV Seronegativity
  
• Study of HIV Preventive Vaccines Given with or without an Adjuvant in HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00111605 - Active, not recruiting
  HIV Infections
  
• A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult Volunteers
  ClinicalTrials.gov Identifier: NCT00000871 - Active, not recruiting
  HIV Infections
  
• Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
  ClinicalTrials.gov Identifier: NCT00004024 - Active, not recruiting
  adult brain tumor
  
• Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00033423 - Active, not recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma
  
• Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003797 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00014664 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent grade III follicular large cell lymphoma; ...
  
• Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement
  ClinicalTrials.gov Identifier: NCT00022906 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission
  ClinicalTrials.gov Identifier: NCT00002458 - Active, not recruiting
  recurrent neuroblastoma; disseminated neuroblastoma
  
• Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
  ClinicalTrials.gov Identifier: NCT00033748 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; liver metastases
  
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia
  ClinicalTrials.gov Identifier: NCT00004084 - Active, not recruiting
  Leukemia; Lymphoma
  
• Monoclonal Antibodies in Treating Patients with Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00056043 - Active, not recruiting
  recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma; recurrent grade 3 follicular lymphoma
  
• Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV Infection
  ClinicalTrials.gov Identifier: NCT00514605 - Completed
  HIV Infections
  
• Voluntary HIV Counseling, Testing, and Medication for Pregnant Women to Prevent Mother-to-Child HIV Transmission
  ClinicalTrials.gov Identifier: NCT00084045 - Active, not recruiting
  HIV Infections
  
• Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00083603 - Active, not recruiting
  HIV Infections
  
• Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00060346 - Active, not recruiting
  Waldenstrom's Macroglobulinemia
  
• Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521) in Infants Born to HIV Infected Mothers
  ClinicalTrials.gov Identifier: NCT00098163 - Active, not recruiting
  HIV Infections
  
• Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00004889 - Active, not recruiting
  Waldenstrom's Macroglobulinemia
  
• The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV
  ClinicalTrials.gov Identifier: NCT00001105 - Completed
  HIV Infections
  
• An International Study to Evaluate Anti-HIV Therapy Plus Interleukin-2 (rIL-2) in HIV-Positive Patients
  ClinicalTrials.gov Identifier: NCT00004978 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy
  ClinicalTrials.gov Identifier: NCT00002449 - Active, not recruiting
  HIV Infections
  
• Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children
  ClinicalTrials.gov Identifier: NCT00006325 - Active, not recruiting
  HIV Infections
  
• Gemtuzumab in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00022321 - Active, not recruiting
  Refractory Anemia; de novo myelodysplastic syndromes; refractory anemia with ringed sideroblasts; ...
  
• Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy
  ClinicalTrials.gov Identifier: NCT00038259 - Active, not recruiting
  HIV Infections
  
• A Randomized Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult Volunteers
  ClinicalTrials.gov Identifier: NCT00000884 - Active, not recruiting
  HIV Infections
  
• Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00058435 - Active, not recruiting
  stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; ...
  
• Rituximab Plus Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00031902 - Active, not recruiting
  AIDS-related peripheral/systemic lymphoma; AIDS-related diffuse large cell lymphoma; AIDS-related immunoblastic large cell lymphoma; ...
  
• Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00058292 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• HIV in Specific Parts of the Body of Patients Who Are Changing or Starting Potent Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00007488 - Active, not recruiting
  HIV Infections
  
• Stopping and Restarting Anti-HIV Drugs in Children and Adolescents with Low Blood Levels of HIV
  ClinicalTrials.gov Identifier: NCT00016783 - Active, not recruiting
  HIV Infections
  
• Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005959 - Active, not recruiting
  Lymphoma
  
• The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children
  ClinicalTrials.gov Identifier: NCT00006064 - Active, not recruiting
  HIV Infections; HIV Wasting Syndrome; Lipodystrophy
  
• Long-Term Effects of HIV Exposure and Infection in Children
  ClinicalTrials.gov Identifier: NCT00006304 - Active, not recruiting
  HIV Infections; HIV Seronegativity
  
• Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00039091 - Active, not recruiting
  acute leukemia; atypical chronic myeloid leukemia; Melanoma; myelodysplastic and myeloproliferative disease; Non-small cell lung cancer; ...
  
• Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer
  ClinicalTrials.gov Identifier: NCT00001507 - Recruiting
  Breast Neoplasm; Neoplasm Metastasis
  
• Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00061243 - Active, not recruiting
  HIV Infections
  
• Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients with CD4 Cell Counts of at Least 350 Cells/mm3
  ClinicalTrials.gov Identifier: NCT00000948 - Active, not recruiting
  HIV Infections
  
• The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients with CD4 Cell Counts of at Least 350 Cells/mm3
  ClinicalTrials.gov Identifier: NCT00000825 - Active, not recruiting
  HIV Infections
  
• A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years
  ClinicalTrials.gov Identifier: NCT00006509 - Active, not recruiting
  HIV Infections